Pfizer C3651010
A 6-Week, Randomized, Double-Blind, Sponsor-Open Study To Assess The Effect Of Repeated Subcutaneous Administration Of Pf-06946860 On Appetite In Participants With Advanced Cancer And Anorexia, Followed By An 18-Week Open-Label Treatment Period
©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.